| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2009 | US20090181893 Use of agents that prevent generation of amyloid and amyloid-like lipoproteins, and/or use of agents that promote sequestration and/or degradation of, and/or prevent neurotoxicity of such proteins in the treatment of hearing loss and improving body balance |
| 07/16/2009 | US20090181889 Compositions and methods for detection and treatment of human herpesvirus (hhv)-6 |
| 07/16/2009 | US20090181437 Method for producing a conjugated linoleic acid glyceride |
| 07/16/2009 | US20090181407 Method and kit for detecting the early onset of renal tubular cell injury |
| 07/16/2009 | US20090181150 Cholesterol lowering supplement and low cholesterol egg produced by using the same |
| 07/16/2009 | US20090181111 Saponin And Preservative Compositions For Reduction of Protozoa |
| 07/16/2009 | US20090181110 Compositions from Garcinia as Aromatase Inhibitors for Breast Cancer Chemoprevention and Chemotherapy |
| 07/16/2009 | US20090181109 Nanoveson™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases |
| 07/16/2009 | US20090181108 Use of Bisphosphonates for Otosclerosis |
| 07/16/2009 | US20090181101 Nanoparticles comprising antibacterial ligands |
| 07/16/2009 | US20090181100 Dry powder aerosols of Nanoparticulate drugs |
| 07/16/2009 | US20090181099 Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| 07/16/2009 | US20090181091 Product and process to regulate a gene network involved in constitutive inflammation and early cancer progression |
| 07/16/2009 | US20090181090 Protein-Based Carrier System for Overcoming Resistance in Tumour Cells |
| 07/16/2009 | US20090181088 Thermosensitive polyphosphazene-bioactive molecule conjugates, preparation method thereof and use thereof |
| 07/16/2009 | US20090181085 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 07/16/2009 | US20090181084 Oral fast-disintegrating tablet including particles of slowly-releaseable ascorbic acid |
| 07/16/2009 | US20090181081 Systemic Treatment of Pathological Conditions Resulting From Oxidative Stress and/or Redox Imbalance |
| 07/16/2009 | US20090181080 Oral cannabinnoid liquid formulations and methods of treatment |
| 07/16/2009 | US20090181079 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 07/16/2009 | US20090181077 Detection of pkc-iota as a biomarker for brain tumorigenesis |
| 07/16/2009 | US20090181076 Drug Release From Nanoparticle-Coated Capsules |
| 07/16/2009 | US20090181075 Drospirenone containing transdermal drug delivery devices and methods of delivery thereof |
| 07/16/2009 | US20090181067 Immobilized biologically active entities having high biological activity following mechanical manipulation |
| 07/16/2009 | US20090181066 Immobilized biologically active entities having high biological activity folowing mechanical manipulation |
| 07/16/2009 | US20090181065 Methods and devices for promoting endothelial morphogenesis |
| 07/16/2009 | US20090181063 Implantable medical device comprising a pro-healing poly(ester-amide) |
| 07/16/2009 | US20090181060 Skin-care compositions |
| 07/16/2009 | US20090181058 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 07/16/2009 | US20090181044 Novel Flavivirus antigens |
| 07/16/2009 | US20090181042 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
| 07/16/2009 | US20090181040 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
| 07/16/2009 | US20090181029 Methods for treating interleukin-6 related diseases |
| 07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/16/2009 | US20090181010 Arginase II: a target for the prevention of atherosclerosis |
| 07/16/2009 | US20090180999 Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition |
| 07/16/2009 | US20090180995 Novel anticoagulant polypeptides and complex |
| 07/16/2009 | US20090180990 Composition for maintaining healthy kidney function |
| 07/16/2009 | US20090180988 Id-1 and Id-2 Genes and Products as Therapeutic Targets for Treatment of Breast Cancer and Other Types of Carcinoma |
| 07/16/2009 | US20090180986 Treating unwanted ocular conditions using an ascomycin macrolactam |
| 07/16/2009 | US20090180985 Bridged carbocyclic oxime hepatitis c virus serine protease inhibitors |
| 07/16/2009 | US20090180984 Macrocyclic oximyl hepatitis c serine protease inhibitors |
| 07/16/2009 | US20090180983 Bicyclic, c5-substituted proline derivatives as inhibitors of the hepatitis c virus ns3 protease |
| 07/16/2009 | US20090180980 Anti-Arenaviral Compunds |
| 07/16/2009 | US20090180975 Polynucleotide Fragments Of An Infectious Human Endogenous Retrovirus |
| 07/16/2009 | US20090180974 Agent For Protecting Body Cells |
| 07/16/2009 | US20090180971 Method for the prevention and/or activation of defense mechanisms in the human body against conditions, disorders or diseases relating to the presence of free radicals, such as: environmental pollution, aging or smoking |
| 07/16/2009 | US20090180957 Identification of a micro-rna that activates expression of beta-myosin heavy chain |
| 07/16/2009 | US20090180923 Self-mixing container with a releasable internal vessel and its usage |
| 07/16/2009 | DE10301300B4 Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein Use of acylated 4-amidino and 4-Guanidinobenzylaminen for the inhibition of plasma kallikrein |
| 07/16/2009 | DE102008004100A1 New metallocene compounds are estrogen receptor modulators useful e.g. to treat preferably cancer, manic disorder, gynecomastia and/or female infertility, and to prevent mamma carcinoma |
| 07/16/2009 | DE102008004090A1 Biochemical or pharmaceutical mixture comprises co-enzyme Q10 (ubiquinone), where the co-enzyme Q10 are transported to the animal/human cells through cell membrane by isotonic saline solution (sodium chloride) and/or L-lysine, as carrier |
| 07/16/2009 | DE10140361B4 Verwendung einer Biguanide enthaltenden Zubereitung zur Hufpflege Containing biguanides using a preparation for hoof care |
| 07/16/2009 | CA2794054A1 Proline analogs as ligands for cannabinoid receptors |
| 07/16/2009 | CA2749273A1 Pharmaceutical compositions |
| 07/16/2009 | CA2738458A1 Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 07/16/2009 | CA2727055A1 (1-azinone) -substituted pyridoindoles as mch antagonists |
| 07/16/2009 | CA2714888A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 07/16/2009 | CA2711862A1 Composition for improving nutritional status of the elderly, reducing frequency of fever of the elderley and/or increasing immunocompetence of the elderly |
| 07/16/2009 | CA2711840A1 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy |
| 07/16/2009 | CA2711834A1 Synthetic triterpenoids and methods of use in the treatment of disease |
| 07/16/2009 | CA2711817A1 Rasagiline formulations, their preparation and use |
| 07/16/2009 | CA2711815A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/16/2009 | CA2711814A1 Capsule formulation |
| 07/16/2009 | CA2711809A1 Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly |
| 07/16/2009 | CA2711807A1 Agonists for antimicrobial peptide systems |
| 07/16/2009 | CA2711803A1 Pyridine derivatives |
| 07/16/2009 | CA2711782A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
| 07/16/2009 | CA2711741A1 Pyrazolopyridines as kinase inhibitors |
| 07/16/2009 | CA2711734A1 Method and compositions for administering resveratrol and pterostilbene |
| 07/16/2009 | CA2711699A1 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 07/16/2009 | CA2711692A1 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor |
| 07/16/2009 | CA2711687A1 Analgesic apatitic calcium-phosphate cement |
| 07/16/2009 | CA2711678A1 Inhibitors of carbonic anhydrase ix |
| 07/16/2009 | CA2711675A1 Pharmaceutical compositions and methods utilizing a d-amino acid and an antioxidant for treating neuropsychiatric disorders |
| 07/16/2009 | CA2711652A1 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | CA2711637A1 Pyrimidines as kinase inhibitors |
| 07/16/2009 | CA2711614A1 Pyrrolopyridines as kinase inhibitors |
| 07/16/2009 | CA2711612A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | CA2711611A1 Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 07/16/2009 | CA2711605A1 Neuroactive steroid compositions and methods of use therefor |
| 07/16/2009 | CA2711603A1 Activators of executioner procaspases 3, 6 and 7 |
| 07/16/2009 | CA2711508A1 Proline analogs as ligands for cannabinoid receptors |
| 07/16/2009 | CA2711491A1 Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide |
| 07/16/2009 | CA2711466A1 Process for the preparation of sulfamide derivatives |
| 07/16/2009 | CA2711464A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/16/2009 | CA2711434A1 Epoxy-guaiane derivatives and treatment of cancer |
| 07/16/2009 | CA2711408A1 Trpa1 antagonists |
| 07/16/2009 | CA2711334A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 07/16/2009 | CA2711292A1 Inhalation drug products, systems and uses |
| 07/16/2009 | CA2711288A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2009 | CA2711240A1 Liver screening method |
| 07/16/2009 | CA2711221A1 Triarylmethane analogs and their use in treating cancers |
| 07/16/2009 | CA2711217A1 Antimicrobial compositions |
| 07/16/2009 | CA2711179A1 Rna interference for the treatment of heart failure |
| 07/16/2009 | CA2711160A1 Pterin analog for treating bh4 responsive condition |
| 07/16/2009 | CA2711159A1 Trpa1 antagonists |
| 07/16/2009 | CA2710913A1 Use of a gamma-secretase inhibitor for treating cancer |
| 07/16/2009 | CA2710800A1 Process for the preparation of asenapine and intermediate products used in said process |